CN Mobile Logo

Search form


Cancer Complications

Cancer Complications

Venous thromboembolism is significantly more likely over the long term in breast cancer patients than in the general population, according to a study in Sweden.

Due to the delicate hemostatic balance in cancer patients, an understanding of both the clotting and bleeding risks in this population is crucial to effectively manage hematologic complications.

A study of patients receiving rituximab therapy found that screening for hepatitis B virus infection (HBV) was suboptimal, and some patients who did not receive antiviral treatment experienced HBV reactivation or flare. Screening rates, however, do appear to be improving over time.

Pneumonitis occurs in approximately 5% of cancer patients treated with anti–PD-1/PD-L1 immunotherapy agents.

Current guidelines recommend antimicrobial prophylaxis with fluoroquinolones in patients at high risk for infection-related morbidity and mortality, but this practice provides a short-term benefit to individual patients.

Survivors of childhood cancers are at significantly increased risk of cardiotoxicity if treated with anthracyclines, according to a new review of the literature.

A largely self-administered comprehensive geriatric assessment can be used to create a deficit-accumulation frailty index in cancer patients undergoing chemotherapy.


Subscribe to Cancer Complications on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.